• news-banner

    Expert Insights

Some key takeaways from the draft legislation for Finance Bill 2022-23

In July 2022, the government published draft legislation ahead of potential inclusion in Finance Bill 2022-23.  A number of these measures will impact on the life sciences sector, including in particular R&D tax relief reform, draft legislation for the implementation of the OECD Pillar 2 reforms in the UK and a new requirement relating to transfer pricing documentation.  Some of the most important aspects of the changes are briefly explained below.

Research and development

The UK research and development (R&D) tax regime enables sectors such as life sciences to thrive and provides an important incentive to businesses to invest in research and development.

At Budget 2021, the government announced a number of measures that will take effect for accounting periods commencing on or after 1 April 2023 in respect of R&D tax relief.  Draft legislation was published on 20 July 2022 and life sciences businesses should ensure that they understand the implications for them.

One of the most important changes is the focusing of R&D relief for subcontracted work and the cost of externally provided workers to activity in the UK.  The expenditure must now be UK or qualifying overseas expenditure in order to be eligible for relief.  This means expenditure that is attributable to relevant R&D undertaken in the UK or that certain conditions are necessary for the purposes of the R&D that are not present in the UK and which it would be wholly unreasonable for the company to replicate in the UK.  This exception is very narrowly drawn, and a number of businesses are likely to be affected by this change.

The process for making claims will also be changing.  All claims will in the future be required to be made digitally and those claims will be required to provide a breakdown of the expenditure into various categories.  The claim will need to be endorsed by a senior officer.  Claimants will also be required to notify HMRC at least six months prior to the end of the period to which the claim relates that they intend to claim, unless they have claimed in one of the three preceding accounting periods.  Life sciences businesses should ensure they adjust their administrative systems well in advance of the changes coming into effect.

There are a number of other changes, including in relation to time limits and providing a smoother transition for companies moving from the SME scheme to the research and development expenditure credit scheme for larger groups.

OECD reforms

Pillar 2

This measure implements a new tax on UK parents of large multinational groups.  It will impact groups with UK activities where in at least two of the previous four accounting periods, annual global revenues of the group were in excess of EUR 750 million. 

Where the parent entity of the group is in the UK, it will be liable for additional tax where any non-UK members in the group do not bear tax on their profits at a rate of at least 15%.  Complex provisions apply to the computation of profits and losses and the effective tax rate.

Transfer pricing documentation

Draft legislation has also been published relating to the transfer pricing documentation requirements applicable to large multinational groups, following earlier consultation.  The new requirements will provide for master file, local file and summary audit trail questionnaire documents to be kept.  The master file will contain information relating to all of the group members and the local file will relate to transactions for the local taxpayer.  The summary audit trail will require the group to complete a questionnaire in respect of the preparation of the local file document.

For more information on the above please contact Helen Coward or your usual Charles Russell Speechlys contact.

Our thinking

  • Mental Health Management

    Nick Hurley

    Events

  • Calculating Social Value in BTR

    Francis Ho

    Events

  • Dangers of trusts

    Mark Summers

    Events

  • The Evening Standard quotes Rose Carey on the increase in visa fees

    Rose Carey

    In the Press

  • Charles Russell Speechlys advises Zenzero’s management team on its majority acquisition by Macquarie Capital

    Mark Howard

    News

  • Updates and points to note in relation to buy-to-let residential properties

    Twiggy Ho

    Insights

  • Felicity Chapman writes for Insider Media on alternatives to court for divorcing business owners

    Felicity Chapman

    In the Press

  • Investment Week quotes Julia Cox on the proposed scrapping of inheritance tax

    Julia Cox

    In the Press

  • Charles Russell Speechlys expands commercial offering with the appointment of Rebecca Steer

    Rebecca Steer

    News

  • The Times quotes Gareth Mills on the CMA’s preliminary approval of the Activision Blizzard-Microsoft deal

    Gareth Mills

    In the Press

  • Heritage property and conditional exemption

    Sarah Wray

    Insights

  • The Financial Times quotes Emma Humphreys on UK rental costs

    Emma Humphreys

    In the Press

  • City AM quotes Gareth Mills on the CMA’s new set of principles for regulating AI

    Gareth Mills

    In the Press

  • Hamish Perry and Mike Barrington write for The Evening Standard on whether a merger between the CBI and Make UK can work

    Hamish Perry

    In the Press

  • Silicon quotes Gareth Mills on the UK consumer lawsuit against Google

    Gareth Mills

    In the Press

  • Property Week quotes Louise Ward on the additional support required by aspiring UK life sciences operators

    Louise Ward

    In the Press

  • Sarah Higgins and David Wells-Cole write for Wealth Briefing on the pitfalls of using unregulated legal services

    Sarah Higgins

    In the Press

  • Charles Russell Speechlys Luxembourg strengthens tax practice with the recruitment of David Cordova Flores

    Yacine Diallo

    News

  • Office to Lab Conversions: A new lease of life (sciences) for some of London’s offices?

    Georgina Muskett

    Quick Reads

  • Charles Russell Speechlys’ UK offices receive environmental certification

    Kerry Stares

    News

  • Case analysis: URS Corporation Ltd V BDW Trading Ltd

    James Worthington

    Insights

  • The Family Fund: Bank of Mum & Dad 2.0

    Vanessa Duff

    Quick Reads

  • The perpetual struggle between the environment, heritage and development: the M&S decision vs 55 Bishopsgate

    Sophie Willis

    Quick Reads

  • Treasury Committee endorses mandatory venture capital diversity policies from 2025

    Lia Renna

    Quick Reads

  • Oops!....I did it again - Britney's third divorce

    Charlotte Posnansky

    Quick Reads

  • Recognising financial abuse in a relationship

    Vanessa Duff

    Quick Reads

  • Making BitCoin a BitClearer

    Charlotte Posnansky

    Quick Reads

  • Key takeaways from the UK Government's "Green Day"

    Martha Glaser

    Quick Reads

  • From Holby City to 5 Fleet Place - David Ames shares his experience of "Behind the Lens" with CRS

    Quick Reads

  • The Domestic Abuse Act 2021 in Action

    Sophia Leeder

    Quick Reads

  • This week in the news: inheritance tax interest costs rising due to Probate delays

    Sarah Wray

    Quick Reads

  • WhatsAppGate - Should businesses be reviewing their social media policies?

    Anna Rogers

    Quick Reads

  • Updates to EMI Options in the Spring Budget 2023

    Quick Reads

  • Dubai announces its plan to streamline the enforcement of civil judgments and arbitral awards

    Peter Smith

    Quick Reads

  • VAT on fund management services

    Robert Birchall

    Quick Reads

  • Time to turn down the lights

    Eddie Richards

    Quick Reads

  • Losing their (Elgin) marbles? British Museum and Greek government fail to reach agreement on the Parthenon sculptures

    Louise Paterson

    Quick Reads

  • Youth Mobility Scheme visa category: now open!

    Kayleigh McKee

    Quick Reads

  • Autumn Statement 2022: Very few surprises

    Robert Birchall

    Quick Reads

  • Part 1: The Tip of the Triangle – Examining London’s Potential in the Life Sciences Sector

    Amy Shuttleworth

    Quick Reads

Back to top